According to Viridian Therapeutics's latest financial reports the company's current revenue (TTM ) is โฌ60.87 Million. In 2024 the company made a revenue of โฌ0.29 Million an increase over the revenue in the year 2023 that were of โฌ0.28 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.